Literature DB >> 23429970

Hepatocellular carcinoma after ablation: the imaging follow-up scheme.

Lin-Na Liu1, Hui-Xiong Xu, Yi-Feng Zhang, Jun-Mei Xu.   

Abstract

Percutaneous ablation using thermal or chemical methods has been widely used in the treatment of hepatocellular carcinoma (HCC). Nowadays, contrast-enhanced imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and contrast-enhanced ultrasound (CEUS) are widely used to evaluate local treatment response after ablation therapies. CEUS is gaining increasing attention due to its characteristics including real-time scanning, easy performance, lack of radiation, wide availability, and lack of allergy reactions. Several studies have documented that CEUS is comparable to CT or MRI in evaluating local treatment efficacy within 1 mo of treatment. However, little information is available regarding the role of CEUS in the follow-up assessment after first successful ablation treatment. Zheng et al found that in comparison with contrast-enhanced computed tomography (CECT), the sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy of CEUS in detecting local tumor progression (LTP) were 67.5%, 97.4%, 81.8%, 94.4% and 92.3%, respectively, and were 77.7%, 92.0%, 92.4%, 76.7% and 84.0%, respectively for the detection of new intrahepatic recurrence. They concluded that the sensitivity of CEUS in detecting LTP and new intrahepatic recurrence after ablation is relatively low in comparison with CECT, and CEUS cannot replace CECT in the follow-up assessment after percutaneous ablation for HCC. These results are meaningful and instructive, and indicated that in the follow-up period, the use of CEUS alone is not sufficient. In this commentary, we discuss the discordance between CT and CEUS, as well as the underlying mechanisms involved. We propose the combined use of CT and CEUS which will reduce false positive and negative results in both modalities. We also discuss future issues, such as an evidence-based ideal imaging follow-up scheme, and a cost-effectiveness analysis of this imaging follow-up scheme.

Entities:  

Keywords:  Computed tomography; Contrast-enhanced ultrasound; Ethanol ablation; Follow-up; Hepatocellular carcinoma; Radiofrequency ablation; Treatment response

Mesh:

Year:  2013        PMID: 23429970      PMCID: PMC3574876          DOI: 10.3748/wjg.v19.i6.797

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  50 in total

1.  Era of diagnostic and interventional ultrasound.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2011-05-28

Review 2.  Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009.

Authors:  Donald Poon; Benjamin O Anderson; Li-Tzong Chen; Koichi Tanaka; Wan Yee Lau; Eric Van Cutsem; Harjit Singh; Wan Cheng Chow; London Lucien Ooi; Pierce Chow; Maung Win Khin; Wen Hsin Koo
Journal:  Lancet Oncol       Date:  2009-11       Impact factor: 41.316

3.  Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Ming-De Lu; Xiao-Yan Xie; Zuo-Feng Xu; Guang-Jian Liu; Lin-Na Liu
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

4.  Magnetic navigation in ultrasound-guided interventional radiology procedures.

Authors:  H-X Xu; M-D Lu; L-N Liu; L-H Guo
Journal:  Clin Radiol       Date:  2011-12-06       Impact factor: 2.350

5.  Contrast-enhanced ultrasound in the biliary system: Potential uses and indications.

Authors:  Hui-Xiong Xu
Journal:  World J Radiol       Date:  2009-12-31

Review 6.  Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.

Authors:  Tae Kyoung Kim; Kyoung Ho Lee; Korosh Khalili; Hyun-Jung Jang
Journal:  Abdom Imaging       Date:  2011-06

7.  Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.

Authors:  H-X Xu; M-D Lu; X-Y Xie; X-Y Yin; M Kuang; J-W Chen; Z-F Xu; G-J Liu
Journal:  Clin Radiol       Date:  2005-09       Impact factor: 2.350

8.  Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?

Authors:  P Ricci; V Cantisani; F Drudi; E Pagliara; M Bezzi; F Meloni; F Calliada; S M Erturk; V D'Andrea; U D'Ambrosio; R Passariello
Journal:  Ultraschall Med       Date:  2009-03-11       Impact factor: 6.548

9.  Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.

Authors:  Hui-Xiong Xu; Xiao-Yan Xie; Ming-De Lu; Guang-Jian Liu; Zuo-Feng Xu; Yan-Lin Zheng; Jin-Yu Liang; Li-Da Chen
Journal:  J Clin Ultrasound       Date:  2008-06       Impact factor: 0.910

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  7 in total

Review 1.  Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.

Authors:  Sonal Krishan; Radha K Dhiman; Navin Kalra; Raju Sharma; Sanjay S Baijal; Anil Arora; Ajay Gulati; Anu Eapan; Ashish Verma; Shyam Keshava; Amar Mukund; S Deva; Ravi Chaudhary; Karthick Ganesan; Sunil Taneja; Ujjwal Gorsi; Shivanand Gamanagatti; Kumble S Madhusudan; Pankaj Puri; Shallini Govil; Manav Wadhavan; Sanjiv Saigal; Ashish Kumar; Shallini Thapar; Ajay Duseja; Neeraj Saraf; Anubhav Khandelwal; Sumit Mukhopadyay; Ajay Gulati; Nitin Shetty; Nipun Verma
Journal:  J Clin Exp Hepatol       Date:  2019-08-06

2.  Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.

Authors:  Yi Gao; Dong-Yan Zheng; Zheng Cui; Yan Ma; Yuan-Zhi Liu; Wei Zhang
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 3.  Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment.

Authors:  Davide Roccarina; Matteo Garcovich; Maria Elena Ainora; Laura Riccardi; Maurizio Pompili; Antonio Gasbarrini; Maria Assunta Zocco
Journal:  World J Hepatol       Date:  2015-07-18

4.  Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study.

Authors:  Si-Min Ruan; Mei-Qing Cheng; Hui Huang; Hang-Tong Hu; Wei Li; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Man-Xia Lin; Wei Wang
Journal:  J Hepatocell Carcinoma       Date:  2022-05-20

Review 5.  Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound.

Authors:  Shu-Guang Zheng; Hui-Xiong Xu; Lin-Na Liu
Journal:  World J Radiol       Date:  2014-01-28

6.  Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Authors:  Kit-Fai Lee; Charing C N Chong; Anthony K W Fong; Andrew K Y Fung; Hon-Ting Lok; Yue-Sun Cheung; John Wong; Paul B S Lai
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

7.  Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors.

Authors:  Li-Yue Sun; Zi-Ming Du; Yu-Ying Liu; Yan-Hong Li; Xiao-Min Liu; Ting Wang; Jian-Yong Shao
Journal:  Cancers (Basel)       Date:  2021-02-07       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.